Falcon Point Capital’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-18,965
| Closed | -$275K | – | 103 |
|
|
2018
Q3 | $275K | Buy |
18,965
+3,921
| +26% | +$56.9K | 0.06% | 87 |
|
|
2018
Q2 | $300K | Buy |
+15,044
| New | +$300K | 0.06% | 103 |
|
|
2018
Q1 | – | Sell |
-9,908
| Closed | -$244K | – | 117 |
|
|
2017
Q4 | $244K | Sell |
9,908
-7,883
| -44% | -$194K | 0.04% | 106 |
|
|
2017
Q3 | $449K | Sell |
17,791
-871
| -5% | -$22K | 0.07% | 98 |
|
|
2017
Q2 | $506K | Buy |
18,662
+5,116
| +38% | +$139K | 0.07% | 101 |
|
|
2017
Q1 | $404K | Buy |
13,546
+5,363
| +66% | +$160K | 0.05% | 102 |
|
|
2016
Q4 | $222K | Buy |
+8,183
| New | +$222K | 0.03% | 106 |
|